Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Abroad (travel likely)RecruitingPHASE2
Conditions
Intrahepatic Cholangiocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Feng Cheng)West China Hospital, Chengdu, Sichuan, China
Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China
Study leads
Feng Cheng, MD
Study Director
The First Affiliated Hospital with Nanjing Medical University